We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App

Roche Demonstrates How Health Networks Are Driving Change in Labs and Beyond

By LabMedica International staff writers
Posted on 07 Aug 2019
Print article
Image: The cobas 8100 automated workflow series (Photo courtesy of Roche).
Image: The cobas 8100 automated workflow series (Photo courtesy of Roche).
Roche Diagnostics (Basel, Switzerland) launched its presence at the American Association for Clinical Chemistry (AACC) 2019 Clinical Lab Expo by showcasing how health networks are driving change in the lab and beyond. Roche showcased the latest solutions from its clinical lab portfolio, including chemistry, molecular and point-of-care diagnostics, automation and digital diagnostics. The company also provided a glimpse into its diagnostics products that are not yet available for sale in the U.S.

Roche continues to expand the Integrated Core Lab by consolidating and integrating a wider range of platforms across other disciplines that include molecular diagnostics and testing in coagulation, hematology and urinalysis. Roche solutions are also designed to address the lab's future needs, with pre-analytics and the next generation of automation that provides the ability to expand into liquid-based cytology and compatible analytics, all potentially connectable. The automation area included a fully automated configuration of an integrated core lab that consolidates routine chemistry and molecular testing.

Among the products highlighted by Roche at AACC 2019 was its cobas pro integrated solutions — an integrated mid-to-high volume solution for clinical chemistry and immunochemistry testing needs that is designed to achieve reduced maintenance and increased throughput through a scalable and modular system. The company showcased cobas prime — a pre-analytical system designed for standard processing and cross-contamination control of molecular samples — and cobas e 801 module — a high-volume immunoassay platform that provides nearly twice the throughput on the same footprint as its predecessor.

Roche also showcased cobas c 513 — a fully automated chemistry analyzer that raises the standard in HbA1c testing throughput — and the cobas 6800 system — a fully-automated, moderate-complexity platform that brings transformational efficiency gains to molecular diagnostics. The company also highlighted the cobas Connection Module (CCM) — a high-volume automation solution that provides connectivity across disciplines and third-party platforms — and the cobas Liat PCR system — a point-of-care analyzer with CLIA-waived, real-time PCR tests for flu A/B, flu A/B + RSV and strep A that provide lab-quality results in 20 minutes or less.

Gold Supplier
Auto Urinary Sediment Analyzer
COL-R Assay
Microbiology IVD System
MALDI Biotyper Sirius One
Multichannel Pipette
CAPPAero 384 Multichannel

Print article


Molecular Diagnostics

view channel
Image: A new blood test could noninvasively and inexpensively detect colorectal cancer (Photo courtesy of Pexels)

Novel Blood Test Could Detect Early-Onset Colorectal Cancer

Colorectal cancer is the fourth most common cancer, according to the U.S. Centers for Disease Control and Prevention. The rate of colon or rectal cancers in people younger than 50 years old has been on... Read more
Copyright © 2000-2022 Globetech Media. All rights reserved.